| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10715762.2015.1108520 |
| P698 | PubMed publication ID | 26480821 |
| P2093 | author name string | Sutapa Mukherjee | |
| Jaydip Biswas | |||
| Madhumita Roy | |||
| Ruma Sarkar | |||
| P2860 | cites work | Reactive oxygen species: role in the development of cancer and various chronic conditions | Q24548312 |
| Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion | Q24683255 | ||
| Hypoxia and oxidative stress in breast cancer. Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer | Q24801745 | ||
| Role of oxidative stress and the microenvironment in breast cancer development and progression | Q27003859 | ||
| Hypoxia-inducible factor 1 and breast cancer metastasis | Q28087393 | ||
| In vitro and in vivo anti-inflammatory activity of a seed preparation containing phenethylisothiocyanate | Q28194109 | ||
| Mechanism-based in vitro screening of potential cancer chemopreventive agents | Q28195340 | ||
| The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? | Q28393090 | ||
| Time-dependent stabilization of hypoxia inducible factor-1α by different intracellular sources of reactive oxygen species | Q28484609 | ||
| Phenethylisothiocyanate alters site- and promoter-specific histone tail modifications in cancer cells | Q28533351 | ||
| Degradation of HIF-1alpha under hypoxia combined with induction of Hsp90 polyubiquitination in cancer cells by hypericin: a unique cancer therapy | Q28740279 | ||
| Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing | Q29617570 | ||
| PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1α expression in MCF-7 breast cancer cells | Q30430373 | ||
| Dietary phenethylisothiocyanate attenuates bowel inflammation in mice | Q33566354 | ||
| Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4 | Q33584212 | ||
| Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival | Q33589309 | ||
| MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice | Q33640030 | ||
| Redox regulation in cancer: a double-edged sword with therapeutic potential | Q33716894 | ||
| Breast cancer metastasis driven by ErbB2 and 14-3-3zeta: A division of labor | Q33781074 | ||
| Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response | Q34375447 | ||
| Inhibition of breast cancer metastases by a novel inhibitor of TGFβ receptor 1. | Q34487585 | ||
| Non-angiogenic functions of VEGF in breast cancer | Q34559451 | ||
| Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancer | Q34734464 | ||
| Cancer and metastasis: prevention and treatment by green tea | Q35125873 | ||
| Novel function of transcription factor Nrf2 as an inhibitor of RON tyrosine kinase receptor-mediated cancer cell invasion | Q35213365 | ||
| A potentially common peptide target in secreted heat shock protein-90α for hypoxia-inducible factor-1α-positive tumors | Q35756686 | ||
| Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity | Q35937789 | ||
| Mitochondrial reactive oxygen species trigger hypoxia-inducible factor-dependent extension of the replicative life span during hypoxia | Q35950224 | ||
| Differential induction of apoptosis in human breast cancer cell lines by phenethyl isothiocyanate, a glutathione depleting agent. | Q36502589 | ||
| Reactive oxygen species and HIF-1 signalling in cancer | Q37124052 | ||
| New developments in Hsp90 inhibitors as anti-cancer therapeutics: mechanisms, clinical perspective and more potential. | Q37215989 | ||
| Expression of matrix metalloproteinases in human breast cancer tissues | Q37260278 | ||
| Cancer cell killing via ROS: to increase or decrease, that is the question | Q37316371 | ||
| Antioxidant and pro-oxidant capacities of ITCs | Q37386837 | ||
| Reactive oxygen species in cancer | Q37431048 | ||
| Metabolic regulation and redox activity as mechanisms for angioprevention by dietary phytochemicals | Q37529631 | ||
| Chemoprevention of dietary digitoflavone on colitis-associated colon tumorigenesis through inducing Nrf2 signaling pathway and inhibition of inflammation | Q37681310 | ||
| Unravelling the complexity of metastasis - molecular understanding and targeted therapies | Q37937424 | ||
| Nutritional strategies to modulate inflammation and oxidative stress pathways via activation of the master antioxidant switch Nrf2. | Q38104172 | ||
| Hemin, an iron-binding porphyrin, inhibits HIF-1α induction through its binding with heat shock protein 90. | Q38476087 | ||
| Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation | Q39004163 | ||
| Targeting heat shock proteins by phenethyl isothiocyanate results in cell-cycle arrest and apoptosis of human breast cancer cells | Q39175428 | ||
| Transcription factor YY1 contributes to tumor growth by stabilizing hypoxia factor HIF-1α in a p53-independent manner. | Q39208900 | ||
| E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells | Q39402009 | ||
| Nrf2-deficiency creates a responsive microenvironment for metastasis to the lung. | Q39698231 | ||
| Overexpression of MMP-9 and HIF-1α in Breast Cancer Cells under Hypoxic Conditions | Q39716859 | ||
| Cul3 overexpression depletes Nrf2 in breast cancer and is associated with sensitivity to carcinogens, to oxidative stress, and to chemotherapy | Q39819761 | ||
| Inhibition of hypoxia inducible factor by phenethyl isothiocyanate. | Q39859462 | ||
| Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell factor (SCF) in response to hypoxia and epidermal growth factor (EGF). | Q40002656 | ||
| Reactive oxygen species stabilize hypoxia-inducible factor-1 alpha protein and stimulate transcriptional activity via AMP-activated protein kinase in DU145 human prostate cancer cells | Q40015395 | ||
| Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation | Q40337557 | ||
| In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways. | Q40457587 | ||
| Interaction of the PAS B domain with HSP90 accelerates hypoxia-inducible factor-1alpha stabilization. | Q40523929 | ||
| Apoptosis Induction by Polygonum minus is related to antioxidant capacity, alterations in expression of apoptotic-related genes, and S-phase cell cycle arrest in HepG2 cell line | Q40557869 | ||
| Hypoxia-induced activation of HIF-1: role of HIF-1alpha-Hsp90 interaction | Q40920382 | ||
| Hsp90 regulates a von Hippel Lindau-independent hypoxia-inducible factor-1 alpha-degradative pathway | Q44019897 | ||
| Hypoxia-inducible factor-1alpha is a key regulator of metastasis in a transgenic model of cancer initiation and progression. | Q46042294 | ||
| Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases | Q46149613 | ||
| Chemoprevention of acrylamide toxicity by antioxidative agents in rats--effective suppression of testicular toxicity by phenylethyl isothiocyanate | Q46466757 | ||
| The time-dependent effect of gluconasturtiin and phenethyl isothiocyanate on metabolic and antioxidative parameters in rats | Q46885760 | ||
| Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. | Q51256046 | ||
| Curcumin augments the efficacy of antitumor drugs used in leukemia by modulation of heat shock proteins via HDAC6. | Q53014973 | ||
| Antioxidant Determinations by the Use of a Stable Free Radical | Q59065485 | ||
| P433 | issue | 1 | |
| P921 | main subject | neoplastic invasiveness | Q112498967 |
| metastatic potential | Q122615215 | ||
| P304 | page(s) | 84-100 | |
| P577 | publication date | 2015-10-19 | |
| P1433 | published in | Free Radical Research | Q5500025 |
| P1476 | title | Phenethyl isothiocyanate, by virtue of its antioxidant activity, inhibits invasiveness and metastatic potential of breast cancer cells: HIF-1α as a putative target | |
| P478 | volume | 50 |
| Q40459695 | Antioxidant and anti-inflammatory effects of Nasturtium officinale involved in attenuation of gentamicin-induced nephrotoxicity. |
| Q55411962 | BAG3 Protein Is Involved in Endothelial Cell Response to Phenethyl Isothiocyanate. |
| Q39429454 | Dietary Natural Products for Prevention and Treatment of Breast Cancer. |
| Q52331716 | Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy. |
| Q48347918 | Inhibition of autophagy potentiates the anti-metastasis effect of phenethyl isothiocyanate through JAK2/STAT3 pathway in lung cancer cells. |
| Q52669816 | Isothiocyanates: cholinesterase inhibiting, antioxidant, and anti-inflammatory activity. |
Search more.